
Indaptus Therapeutics, Inc.
INDPHealthcare|Biotechnology|US
$3.32
+0.16 (+5.06%)
DCF Value
$8.29
Tangible Book / Share
$0.10
Cash / Share
$0.10
Ownership Breakdown
3.6%
Float
113.2M
Shares Outstanding
4.0M
Float Shares
Major Holders (10)
Combined: 191.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Lazar David E. | Individual | 47.93% | 2,064,000 | Mar 24, 2026 | 13D/G |
| Xu Chenhao | Individual | 34.30% | 38,895,000 | Apr 29, 2026 | 13D/G |
| Yao Yun | Individual | 27.34% | 41,991,000 | Oct 22, 2026 | 13D/G |
| Sino Lion Ventures Ltd | Corporation | 25.32% | 38,895,000 | Oct 22, 2026 | 13D/G |
| Chenhao Xu | Individual | 25.32% | 38,895,000 | Oct 22, 2026 | 13D/G |
| Dai Junyi | Individual | 7.33% | 11,250,000 | Oct 22, 2026 | 13D/G |
| Jeffrey A. Meckler | Individual | 6.90% | 875,704 | Nov 26, 2024 | 13D/G |
| Yang Ting | Individual | 6.48% | 9,948,173 | Oct 21, 2026 | 13D/G |
| Newman Michael James | Individual | 5.40% | 115,552 | Dec 30, 2025 | 13D/G |
| Deng Lina | Individual | 4.90% | 5,550,000 | Apr 29, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 484,892 acquired · 913,488 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lu Qinglai | director: | Apr 8, 2026 | OTHER | 0 | — | — | Form 4 |
| Yao Yun | 10 percent owner | Mar 23, 2026 | OTHER | 0 | — | — | Form 4 |
| SINO LION VENTURES Ltd | 10 percent owner | Mar 23, 2026 | OTHER | 0 | — | — | Form 4 |
| Dai Junyi | Chief Executive Officer | Mar 23, 2026 | OTHER | 0 | — | — | Form 4 |
| Lazar David E. | director | Mar 23, 2026 | SELL | 196,800 | — | — | Form 4 |
| Lazar David E. | director | Mar 23, 2026 | SELL | 700,000 | — | — | Form 4 |
| Jabbour Jerome D | director | Feb 26, 2026 | AWARD | 25,000 | $2.06 | $51.5K | Form 4 |
| Jabbour Jerome D | director: | Feb 26, 2026 | OTHER | 0 | — | — | Form 4 |
| McMurdo Matthew Charles | director | Feb 26, 2026 | OTHER | 0 | — | — | Form 4 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | Feb 11, 2026 | AWARD | 12,136 | $1.75 | $21.2K | Form 4 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | Feb 11, 2026 | AWARD | 3,033 | $1.75 | $5.3K | Form 4 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | Feb 11, 2026 | AWARD | 1,519 | $1.75 | $2.7K | Form 4 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | Feb 11, 2026 | DISPOSED | 12,136 | $8.30 | $100.7K | Form 4 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | Feb 11, 2026 | DISPOSED | 3,033 | $47.60 | $144.4K | Form 4 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | Feb 11, 2026 | DISPOSED | 1,519 | $29.40 | $44.7K | Form 4 |
| Ben-Tzvi Avraham | director | Jan 20, 2026 | AWARD | 25,000 | — | — | Form 4 |
| Ben-Tzvi Avraham | director | Dec 23, 2025 | AWARD | 25,000 | $1.95 | $48.8K | Form 4 |
| NATAN DAVID | director | Jan 7, 2026 | AWARD | 25,000 | $2.69 | $67.3K | Form 4 |
| NATAN DAVID | director | Jan 8, 2026 | OTHER | 0 | — | — | Form 4 |
| Sassi Nir | Chief Financial Officer | Dec 22, 2025 | AWARD | 26,758 | $2.03 | $54.3K | Form 4 |
| Meckler Jeffrey A | director, 10 percent owner, officer: Co-Chief Executive Officer | Dec 22, 2025 | AWARD | 216,617 | $2.03 | $439.7K | Form 4 |
| Newman Michael James | director, officer: CSO and Director | Dec 22, 2025 | AWARD | 52,204 | $2.03 | $106.0K | Form 4 |
| Linscott Walt Addison | Chief Operating Officer | Dec 22, 2025 | AWARD | 54,421 | $2.03 | $110.5K | Form 4 |
| Lazar David E. | Co-Chief Executive Officer | Dec 22, 2025 | OTHER | 105,000,000 | — | — | Form 4 |
| Lazar David E. | Co-Chief Executive Officer | Dec 22, 2025 | OTHER | 6,000,000 | — | — | Form 4 |
| Lazar David E. | Co-Chief Executive Officer | Dec 22, 2025 | OTHER | 0 | — | — | Form 4 |
| Ben-Tzvi Avraham | director | Dec 22, 2025 | OTHER | 0 | — | — | Form 4 |
| Meckler Jeffrey A | director, officer: Chief Executive Officer | Jul 27, 2025 | AWARD | 12,136 | $8.30 | $100.8K | Form 4 |
| Meckler Jeffrey A | director, officer: Chief Executive Officer | Jul 27, 2025 | AWARD | 6,068 | $8.30 | $50.4K | Form 4 |
| Karah Hila | director | Jun 10, 2025 | AWARD | 12,500 | $0.33 | $4.1K | Form 4 |
| Martell Robert | director | Jun 10, 2025 | AWARD | 12,500 | $0.33 | $4.1K | Form 4 |
| Hayes William B | director | Jun 10, 2025 | AWARD | 12,500 | $0.33 | $4.1K | Form 4 |
| MADDALUNA ANTHONY J | director | Jun 10, 2025 | AWARD | 12,500 | $0.33 | $4.1K | Form 4 |
| Pomerantz Roger | director | Jun 10, 2025 | AWARD | 30,000 | $0.33 | $9.9K | Form 4 |
| Gilbert Mark John | director | Jun 10, 2025 | AWARD | 12,500 | $0.33 | $4.1K | Form 4 |
| Meckler Jeffrey A | director, officer: CEO and Director | Nov 25, 2024 | AWARD | 42,553 | $1.18 | $50.0K | Form 4 |
| Meckler Jeffrey A | director, officer: CEO and Director | Nov 25, 2024 | AWARD | 42,553 | $1.05 | $44.7K | Form 4 |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | Oct 9, 2024 | AWARD | 75,000 | $1.10 | $82.9K | Form 4 |
| Sassi Nir | Chief Financial Officer | Oct 9, 2024 | AWARD | 75,000 | $1.10 | $82.9K | Form 4 |
| Waltzman Roger J. | Chief Medical Officer | Oct 9, 2024 | AWARD | 75,000 | $1.10 | $82.9K | Form 4 |
| Linscott Walt Addison | Chief Operating Officer | Oct 9, 2024 | AWARD | 75,000 | $1.10 | $82.9K | Form 4 |
| Meckler Jeffrey A | director, officer: CEO and Director | Oct 9, 2024 | AWARD | 75,000 | $1.10 | $82.9K | Form 4 |
| Meckler Jeffrey A | director, officer: CEO and Director | Aug 8, 2024 | AWARD | 84,932 | $1.82 | $155.0K | Form 4 |
| Meckler Jeffrey A | director, officer: CEO and Director | Aug 8, 2024 | AWARD | 84,932 | $1.70 | $144.4K | Form 4 |
| Karah Hila | director | Jun 6, 2024 | AWARD | 12,500 | $2.63 | $32.9K | Form 4 |
| Gilbert Mark John | director | Jun 6, 2024 | AWARD | 12,500 | $2.63 | $32.9K | Form 4 |
| Pomerantz Roger | director | Jun 6, 2024 | AWARD | 30,000 | $2.63 | $78.9K | Form 4 |
| MADDALUNA ANTHONY J | director | Jun 6, 2024 | AWARD | 12,500 | $2.63 | $32.9K | Form 4 |
| Martell Robert | director | Jun 6, 2024 | AWARD | 12,500 | $2.63 | $32.9K | Form 4 |
| Hayes William B | director | Jun 6, 2024 | AWARD | 12,500 | $2.63 | $32.9K | Form 4 |
| Linscott Walt Addison | Chief Operating Officer | Jan 22, 2024 | AWARD | 75,000 | $1.74 | $130.5K | Form 4 |
| Waltzman Roger J. | Chief Medical Officer | Jan 22, 2024 | AWARD | 75,000 | $1.74 | $130.5K | Form 4 |
| Sassi Nir | Chief Financial Officer | Jan 22, 2024 | AWARD | 40,000 | $1.74 | $69.6K | Form 4 |
| Meckler Jeffrey A | director, officer: CEO and Director | Jan 22, 2024 | AWARD | 100,000 | $1.74 | $174.0K | Form 4 |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | Jan 22, 2024 | AWARD | 43,250 | $1.74 | $75.3K | Form 4 |
| Anderson Glen R. | 10 percent owner | Aug 14, 2023 | BUY | 23,934 | $2.34 | $56.0K | Form 4 |
| Anderson Glen R. | 10 percent owner | Aug 11, 2023 | BUY | 35,064 | $2.12 | $74.3K | Form 4 |
| Anderson Glen R. | 10 percent owner | Aug 10, 2023 | BUY | 44,354 | $1.94 | $86.0K | Form 4 |
| Waltzman Roger J. | Chief Medical Officer | Aug 7, 2023 | AWARD | 90,000 | $1.85 | $166.5K | Form 4 |
| Waltzman Roger J. | officer | Aug 7, 2023 | OTHER | 0 | — | — | Form 4 |
| Karah Hila | director | May 25, 2023 | AWARD | 12,500 | $1.82 | $22.8K | Form 4 |
| Hayes William B | director | May 25, 2023 | AWARD | 12,500 | $1.82 | $22.8K | Form 4 |
| Gilbert Mark John | director | May 25, 2023 | AWARD | 12,500 | $1.82 | $22.8K | Form 4 |
| Pomerantz Roger | director | May 25, 2023 | AWARD | 30,000 | $1.82 | $54.6K | Form 4 |
| MADDALUNA ANTHONY J | director | May 25, 2023 | AWARD | 12,500 | $1.82 | $22.8K | Form 4 |
| Martell Robert | director | Feb 13, 2023 | AWARD | 20,000 | $1.71 | $34.2K | Form 4 |
| Martell Robert | director: | Feb 13, 2023 | OTHER | 0 | — | — | Form 4 |
| Meckler Jeffrey A | CEO and Director | Jan 18, 2023 | AWARD | 100,000 | — | — | Form 4 |
| Linscott Walt Addison | Chief Business Officer | Jan 18, 2023 | AWARD | 40,000 | — | — | Form 4 |
| Sassi Nir | Chief Financial Officer | Jan 18, 2023 | AWARD | 40,000 | — | — | Form 4 |
| Newman Michael James | CSO and Director | Jan 18, 2023 | AWARD | 43,250 | — | — | Form 4 |
| Litchev Boyan Vesselinov | Chief Medical Officer | Dec 1, 2022 | BUY | 500 | $1.87 | $935.45 | Form 4 |
| Litchev Boyan Vesselinov | Chief Medical Officer | Nov 22, 2022 | BUY | 500 | $1.83 | $915.00 | Form 4 |
| Litchev Boyan Vesselinov | Chief Medical Officer | Mar 2, 2022 | BUY | 50 | $4.09 | $204.63 | Form 4 |
| Litchev Boyan Vesselinov | Chief Medical Officer | Jan 31, 2022 | BUY | 100 | $4.65 | $465.00 | Form 4 |
| Meckler Jeffrey A | CEO and Director | Nov 21, 2022 | BUY | 9,600 | $1.90 | $18.2K | Form 4 |
| Meckler Jeffrey A | CEO and Director | Nov 18, 2022 | BUY | 400 | $1.76 | $705.48 | Form 4 |
| Karah Hila | director: | Sep 30, 2022 | AWARD | 13,750 | — | — | Form 4 |
| Pomerantz Roger | director: | Sep 30, 2022 | AWARD | 81,000 | — | — | Form 4 |
| Gilbert Mark John | director: | Sep 30, 2022 | AWARD | 13,750 | — | — | Form 4 |
| O'CALLAGHAN BRIAN | director: | Sep 30, 2022 | AWARD | 13,750 | — | — | Form 4 |
| MADDALUNA ANTHONY J | director: | Sep 30, 2022 | AWARD | 13,750 | — | — | Form 4 |
| Hayes William B | director: | Sep 30, 2022 | AWARD | 13,750 | — | — | Form 4 |
| Meckler Jeffrey A | CEO and Director | Sep 8, 2022 | BUY | 10,308 | $2.80 | $28.9K | Form 4 |
| Linscott Walt Addison | Chief Business Officer | Sep 7, 2022 | BUY | 150 | $2.62 | $393.00 | Form 4 |
| Meckler Jeffrey A | CEO and Director | Sep 6, 2022 | BUY | 8,632 | $2.57 | $22.2K | Form 4 |
| Anderson Glen R. | 10 percent owner | Jun 27, 2022 | OTHER | 0 | — | — | Form 4 |
| Anderson Glen R. | 10 percent owner | Jun 27, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Meckler Jeffrey A | CEO and Director | Jun 6, 2022 | BUY | 19,727 | $2.63 | $51.9K | Form 4 |
| Sassi Nir | Chief Financial Officer | Feb 25, 2022 | AWARD | 60,000 | $4.18 | $250.8K | Form 4 |
| Litchev Boyan Vesselinov | Chief Medical Officer | Feb 1, 2022 | AWARD | 90,000 | $4.97 | $447.3K | Form 4 |
| Litchev Boyan Vesselinov | officer | Jan 31, 2022 | OTHER | 0 | — | — | Form 4 |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | Jan 31, 2022 | SELL | 5,870 | $5.00 | $29.4K | Form 4 |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | Feb 1, 2022 | SELL | 14,130 | $5.00 | $70.7K | Form 4 |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | Jan 26, 2022 | AWARD | 43,350 | $4.90 | $212.4K | Form 4 |
| Meckler Jeffrey A | director, officer: CEO and Director | Jan 26, 2022 | AWARD | 200,000 | $4.90 | $980.0K | Form 4 |
| Linscott Walt Addison | Chief Business Officer | Jan 26, 2022 | AWARD | 45,850 | $4.90 | $224.7K | Form 4 |
| Gilbert Mark John | director | Dec 1, 2021 | AWARD | 20,000 | $5.35 | $107.0K | Form 4 |
| Gilbert Mark John | director: | Nov 29, 2021 | OTHER | 0 | — | — | Form 4 |
| Meckler Jeffrey A | director, officer: CEO and Director | Nov 18, 2021 | BUY | 11,187 | $5.82 | $65.1K | Form 4 |